Fluarix Quadrivalent
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Fluarix Quadrivalent, covering 2020-06-12 to 2023-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea [Phase 3]